UNC- Chapel Hill — Chapel Hill, North Carolina

UNC- Chapel Hill is a clinical research site located in Chapel Hill, North Carolina, United States 27599.

Crixeo Health Trust Score: 75/100 (FAIR). This profile has not yet been claimed by the site owner.

UNC- Chapel Hill has participated in 8 clinical trials with 3 currently active.

Therapeutic areas: Gastric Cancer, Cardiovascular Risk, Chronic Kidney Disease.

Sponsors: Five Prime Therapeutics, Inc., Novo Nordisk A/S, UNC Lineberger Comprehensive Cancer Center.

Sponsor Feasibility Report

Trust Score: 75/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UNC- Chapel Hill?

UNC- Chapel Hill has a Crixeo Trust Score of 75/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UNC- Chapel Hill conducted?

UNC- Chapel Hill has 8 clinical trials on record, with 3 currently active. Their work covers Gastric Cancer, Cardiovascular Risk, Chronic Kidney Disease.

Is UNC- Chapel Hill accredited by Crixeo Health?

Yes — UNC- Chapel Hill holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about UNC- Chapel Hill?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.